Skip to content

Author

Pingping Zhu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Integrative 3D genome and epigenomic analysis identifies TP53RK and SYBU as critical regulators of stemness and anti-tumor immunity in HCC.

The 3D genome architecture is identified as a key determinant of tumor stemness and the combined inhibition of TP53RK and PD-1 markedly enhances anti-tumor immunity and highlights TP53RK as a promising therapeutic target in HCC.

Yan-Mei Yang, Peixian Li, Liangbo Zhao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.